SR ONE CAPITAL MANAGEMENT, LLC has filed 61 insider transactions across 4 companies since May 2023.
Most recent transaction: a transaction of 764312 shares of Odyssey Therapeutics, Inc. ($ODTX) on May 11, 2026.
Activity breakdown: 10 open-market purchases and 7 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | X | Series D Warrants (Right to Buy) | 764312 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 204658 | $0.00 | 3,425,227.0000 | 0 | 6.35% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 20582 | $0.00 | 3,445,809.0000 | 0 | 0.60% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 166168 | $0.00 | 3,611,977.0000 | 0 | 4.82% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | X | Common Stock | 49850 | $0.00 | 3,661,827.0000 | 0 | 1.38% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | S | Common Stock | 277 | $18.00 | 3,661,550.0000 | 0 | 0.01% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 133333 | $18.00 | 3,794,883.0000 | 0 | 3.64% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 463106 | $0.00 | 3,243,138.0000 | 0 | 16.66% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 273527 | $0.00 | 3,516,665.0000 | 0 | 8.43% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | X | Common Stock | 78656 | $0.00 | 3,595,321.0000 | 0 | 2.24% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | S | Common Stock | 438 | $18.00 | 3,594,883.0000 | 0 | 0.01% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 200000 | $18.00 | 3,794,883.0000 | 0 | 5.56% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series A Convertible Preferred Stock | 4606320 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series A-2 Convertible Preferred Stock | 1299842 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series B Convertible Preferred Stock | 544162 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 600142 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series D Convertible Preferred Stock | 6644650 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | X | Series D Warrants (Right to Buy) | 1861211 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series A Convertible Preferred Stock | 1151580 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series B Convertible Preferred Stock | 2374981 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series B Convertible Preferred Stock | 1899984 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 200000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series D Convertible Preferred Stock | 1614650 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | X | Series D Warrants (Right to Buy) | 484395 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 4500000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series D Convertible Preferred Stock | 2657860 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 474048 | $0.00 | 2,437,548.0000 | 0 | 24.14% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 139366 | $0.00 | 2,576,914.0000 | 0 | 5.72% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 59692 | $0.00 | 2,636,606.0000 | 0 | 2.32% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 61762 | $0.00 | 2,698,368.0000 | 0 | 2.34% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 683817 | $0.00 | 3,382,185.0000 | 0 | 25.34% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | X | Common Stock | 191541 | $0.00 | 3,573,726.0000 | 0 | 5.66% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | S | Common Stock | 1065 | $18.00 | 3,572,661.0000 | 0 | 0.03% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 222222 | $18.00 | 3,794,883.0000 | 0 | 6.22% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 118512 | $0.00 | 3,539,060.0000 | 0 | 3.46% | 0.00% |
| May 11, 2026 | Odyssey Therapeutics, Inc. | $ODTX | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 255823 | $0.00 | 3,794,883.0000 | 0 | 7.23% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C-1 Convertible Preferred Stock | 6827429 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C-1 Convertible Preferred Stock | 27309719 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 1419298 | $0.00 | 2,541,385.0000 | 0 | 126.49% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 489486 | $0.00 | 3,030,871.0000 | 0 | 19.26% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 277778 | $18.00 | 3,308,649.0000 | 0 | 9.16% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 354824 | $0.00 | 2,541,386.0000 | 0 | 16.23% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 489486 | $0.00 | 3,030,872.0000 | 0 | 19.26% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 277777 | $18.00 | 3,308,649.0000 | 0 | 9.16% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series D Convertible Preferred Stock | 9418560 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 1, 2026 | Avalyn Pharma Inc. | $AVLN | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series D Convertible Preferred Stock | 9418561 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 9, 2025 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 63158 | $19.00 | 5,037,854.0000 | 42,159,340 | 1.27% | 0.15% |
| Oct. 9, 2025 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 63157 | $19.00 | 5,037,854.0000 | 42,159,340 | 1.27% | 0.15% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 441176 | $17.00 | 4,911,539.0000 | 1,567,269 | 9.87% | 28.15% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 501796 | $0.00 | 3,558,597.0000 | 1,567,269 | 16.42% | 32.02% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 1352942 | $17.00 | 4,911,539.0000 | 1,567,269 | 38.02% | 86.33% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 669061 | $0.00 | 4,470,363.0000 | 1,567,269 | 17.60% | 42.69% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 441176 | $17.00 | 4,911,539.0000 | 1,567,269 | 9.87% | 28.15% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 13071439 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 4357146 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 5809528 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 1505388 | $0.00 | 4,470,363.0000 | 1,567,269 | 50.77% | 96.05% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 6485 | $46.15 | 4,487,174.0000 | 0 | 0.14% | 0.00% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 370612 | $45.00 | 4,490,978.0000 | 0 | 7.62% | 0.00% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 631932 | $45.00 | 4,493,659.0000 | 0 | 12.33% | 0.00% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 3804 | $46.15 | 4,487,174.0000 | 0 | 0.08% | 0.00% |